• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Una Ryan: Impact requires understanding

Una Ryan: Impact requires understanding

May 17, 2010 By MassDevice Contributors Network

World Health Medical Technology Conference logo

MassDevice.com is liveblogging the World Health Medical Technology Conference at Boston University.

The World Health Medical Technology Conference is a one-day workshop dedicated to exploring the opportunities and challenges of designing, building and funding medical technologies for the developing world. It’s a way to bring together stakeholders from the medical technology industry with the leading minds in the Global Health movement. To find out more about the conference, visit the conference’s website for an agenda, registration information and a list of speakers.

CEO of Diagnostics For All, Una Ryan, began her remarks at the WHMTC by noting some of the nuances of administering healthcare in developing nations.

Her company, a Cambridge, Mass.-based non-profit that’s developing, paper-based, ultra-low-cost diagnostics for the developing world, said if you want to make the greatest possible impact on a population in a developing nation, you need to understand the population. Developed nations have amazing tech, but no way to get it to people in the developing world, but the logistical problems are far more complicated than distances or even governmental stability.

Ryan said in the developed world has centralized hospitals, highly trained med staff, reliable power and refrigeration, and possibility for follow up appointments, but none of which exist in the developing world.

During her presentation, Ryan put of a slide of the World Health Organization’s (WHO) ASSURED test for any medical test to help illustrate her discussion. All tests must be:
Affordable
Sensitive
Specific
User-friedly
Rapid and Robust
Equipment Free and
Devliverable to end users

Her company created a paper-based product because paper "is the cheapest ubiquitous material in the world," she said. The company’s devices rely on microfluidics, which doesn’t require power, clean water or a skilled staff, and attempts to have zero-cost. The devices resemble postage stamps and are designed to channel bodily fluids through to enable sophisticated testing. If the paper is layered, the tests can be more and more sophisticated.  The organization last week received a Gates Foundation grant to embed electronics into the paper.

Diagnostics for All designed the products to be printed on a device similar to desktop printer, and one printer, which costs $800, can create 71 million stamp-sized diagnostic implements per year. In their business model, which Ryan described as "backwards," the company plans to license their technology to the rest of the world as well, with applications for pediactrics, emergency care, athletes and military. Typcially, for profit companies design products for the wealthiest consumers.

Some key points of DFA’s business model:
The for-profit is a wholly owned subsid of the non-profit.
It relies on academic labs (Harvard’s Whitesides Labs)
They are a 501(c)3 non-profit.
They attempt to rely on local for-profit manufacturing.

Filed Under: Business/Financial News, News Well Tagged With: Diagnostics For All, Trade Show, World Health Medical Technology Conference

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy